Correlation Between AbbVie and Aclaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both AbbVie and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Aclaris Therapeutics, you can compare the effects of market volatilities on AbbVie and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Aclaris Therapeutics.
Diversification Opportunities for AbbVie and Aclaris Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AbbVie and Aclaris is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of AbbVie i.e., AbbVie and Aclaris Therapeutics go up and down completely randomly.
Pair Corralation between AbbVie and Aclaris Therapeutics
Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Aclaris Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AbbVie Inc is 5.4 times less risky than Aclaris Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Aclaris Therapeutics is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 180.00 in Aclaris Therapeutics on August 31, 2024 and sell it today you would earn a total of 202.00 from holding Aclaris Therapeutics or generate 112.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AbbVie Inc vs. Aclaris Therapeutics
Performance |
| Timeline |
| AbbVie Inc |
| Aclaris Therapeutics |
AbbVie and Aclaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Aclaris Therapeutics
The main advantage of trading using opposite AbbVie and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.| AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |